Gilead Sciences, Inc.
PD-1/PD-L1 INHIBITORS
Last updated:
Abstract:
Compounds according to formula (I), methods of using said compounds singly or in combination with additional agents and compositions of said compounds for the treatment of cancer are disclosed.
Status:
Application
Type:
Utility
Filling date:
13 Nov 2020
Issue date:
21 Oct 2021